Unitas Pharma OÜ

12218170

General info

Name

Unitas Pharma OÜ

Registry code

12218170

VAT number

EE101534019

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

12.01.2012 (12)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

47741 - Retail sale of medical and orthopaedic goods in specialised stores

Revenue

379 628 €

Profit

111 851 €

Profit margin

29%

Gross salary

-

Equity

441 628 €

Employees

0

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

25%

Return on assets

24%

Related parties

Owner Representative Beneficial owner Roles

Peep Brandmeister

25.08.1966 (58)

30% - 750.00 EUR - Direct ownership

Carina Truuverk

03.05.1964 (60)

70% - 1 750.00 EUR Board member Direct ownership Founder

Related companies

Owner Representative Beneficial owner Roles

OÜ SolMareOra

16695530

50% - 150.00 EUR - - Founder

Financial info

2019
29.06.2020
2020
31.05.2021
2021
01.07.2022
2022
15.06.2023
2023
28.06.2024
Total Revenue 221 789 € 197 793 € 362 415 € 415 081 € 379 628 €
Net profit (loss) for the period 3 276 € 24 085 € 57 811 € 128 603 € 111 851 €
Profit Margin 1% 12% 16% 31% 29%
Current Assets 127 463 € 172 191 € 220 936 € 314 622 € 388 638 €
Fixed Assets 0 € 3 389 € 3 038 € 20 438 € 76 817 €
Total Assets 127 463 € 175 580 € 223 974 € 335 060 € 465 455 €
Current Liabilities 5 685 € 29 717 € 20 300 € 5 283 € 23 827 €
Non Current Liabilities - - - - -
Total Liabilities - - - - -
Share Capital - - - - -
Equity 121 778 € 145 863 € 203 674 € 329 777 € 441 628 €
Employees 0 0 0 0 0

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 144 422.6 € 5 063.74 € - -
2023 Q4 117 725.38 € 1 400.08 € - -
2023 Q3 86 614.99 € 839.25 € - -
2023 Q2 109 556.8 € 2 962.48 € - -
2023 Q1 100 897.26 € 4 557.12 € - -
2022 Q4 105 512.97 € 7 076.48 € - -
2022 Q3 119 763.27 € 1 993.86 € - -
2022 Q2 80 230.43 € 4 011.17 € - -
2022 Q1 111 498.37 € 4 419.31 € - -
2021 Q4 107 535.49 € 884.28 € - -
2021 Q3 109 672.21 € 5 184.63 € - -
2021 Q2 76 996.71 € 970.23 € - -
2021 Q1 96 044.59 € 3 949.32 € - -
2020 Q4 89 194.62 € 2 848.6 € - -
2020 Q3 63 527.92 € 1 754.97 € - -
2020 Q2 42 008.08 € 740 € - -
2020 Q1 79 485.41 € 3 325.31 € - -